Related Experiment Video
Updated: Jun 3, 2026
14:48
Conversion of a Capture ELISA to a Luminex xMAP Assay using a Multiplex Antibody Screening Method
Published on: July 6, 2012
[HLA and transfusion: new approaches with Luminex™ technology]
C Giannoli1, T-K-T Nguyen, V Dubois
1Laboratoire d'histocompatibilité, site de Lyon, EFS Rhône-Alpes, 1-3, rue du Vercors, 69007 Lyon, France. catherine.giannoli@efs.sante.fr
Summary
Identifying human leukocyte antigen (HLA) class I antibodies is crucial for safe transfusions. Luminex™ technology offers superior sensitivity for detecting these antibodies, improving platelet donor selection and patient outcomes.
Area of Science:
- Immunogenetics
- Transfusion Medicine
- Clinical Immunology
Background:
- The Major Histocompatibility Complex (MHC) encodes Human Leukocyte Antigen (HLA) molecules, critical for immune responses and allograft rejection.
- Anti-HLA antibodies can cause transfusion reactions like fever, TRALI, and platelet refractoriness.
- Accurate identification of HLA class I antibodies is vital for selecting compatible platelet concentrates.
Purpose of the Study:
- To highlight the importance of identifying HLA class I antibodies in transfusion medicine.
- To review the evolution of HLA antibody detection methods.
- To emphasize the advantages of Luminex™ technology for HLA antibody screening.
Main Methods:
- Review of historical and modern techniques for HLA antibody detection.
- Focus on the complement-dependent microlymphocytotoxicity assay (historical standard).
- Comparison with newer sensitive methods: flow cytometry, ELISA, and Luminex™.
Main Results:
- Luminex™ technology provides high sensitivity and specificity for HLA antibody screening.
- Single HLA antigen panel assays using Luminex™ generate informative antibody reactivity patterns.
- Luminex™ enables optimal selection of platelet donors for patients.
Conclusions:
- Luminex™ is the most sensitive method for screening HLA antibodies.
- This technology improves the selection of compatible platelet concentrates.
- Cross-matching remains a valuable option for highly immunized recipients when compatible donors are unavailable.
Related Concept Videos
02:45Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:15Blood Transfusion
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...